---
figid: PMC6424573__nihms-1005542-f0002
figlink: /pmc/articles/PMC6424573/figure/F2/
number: Fig. 2
caption: 'NO is produced from L-arginine by nitric oxide synthase (NOS) of which there
  are three isoforms: neuronal NOS1 (nNOS), endothelial NOS3 (eNOS) and inducible
  NOS2 (iNOS). NO targets guanylate cyclase-1 (GC-1), a heterodimeric protein capable
  of converting GMP to cGMP. cGMP produced by GC-1 can target cGMP-gated ion channels,
  and activate downstream kinase signaling cascades. Phosphodiesterase enzymes (PDE)
  bind to cGMP and catalyse its breakdown into GMP – PDEs act as important regulators
  of signal transduction mediated by cGMP. cGMP bioavailability in the cell can be
  modulated in two ways: 1) through the use of GC-1 stimulators and activators, which
  increase production of cGMP, or, 2) through the use of PDE inhibitors which prevent
  the breakdown of cGMP in the cell.'
pmcid: PMC6424573
papertitle: The Nitric Oxide-Guanylate Cyclase Pathway and Glaucoma.
reftext: Lauren K. Wareham, et al. Nitric Oxide. 2018 Jul 1;77:75-87.
pmc_ranked_result_index: '100054'
pathway_score: 0.9556923
filename: nihms-1005542-f0002.jpg
figtitle: NO-GC-1-cGMP pathway
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6424573__nihms-1005542-f0002.html
  '@type': Dataset
  description: 'NO is produced from L-arginine by nitric oxide synthase (NOS) of which
    there are three isoforms: neuronal NOS1 (nNOS), endothelial NOS3 (eNOS) and inducible
    NOS2 (iNOS). NO targets guanylate cyclase-1 (GC-1), a heterodimeric protein capable
    of converting GMP to cGMP. cGMP produced by GC-1 can target cGMP-gated ion channels,
    and activate downstream kinase signaling cascades. Phosphodiesterase enzymes (PDE)
    bind to cGMP and catalyse its breakdown into GMP – PDEs act as important regulators
    of signal transduction mediated by cGMP. cGMP bioavailability in the cell can
    be modulated in two ways: 1) through the use of GC-1 stimulators and activators,
    which increase production of cGMP, or, 2) through the use of PDE inhibitors which
    prevent the breakdown of cGMP in the cell.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOS1
  - TCF23
  - PDE7B
  - PDE11A
  - PDE1A
  - NOS3
  - PDE2A
  - PDE3A
  - PDE3B
  - PDE1C
  - PDE4B
  - PDE4D
  - PDE6A
  - PDE4A
  - PDE4C
  - PDE10A
  - PDE8A
  - PDE9A
  - PDE1B
  - PDE8B
  - SGCB
  - PDE6C
  - PDE7A
  - PDE6B
  - Ca2
  - Na
  - CGMP
  - 5'GMP
genes:
- word: NNOS
  symbol: nNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: Out
  symbol: OUT
  source: hgnc_alias_symbol
  hgnc_symbol: TCF23
  entrez: '150921'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7B
  entrez: '27115'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE11A
  entrez: '50940'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1A
  entrez: '5136'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE2A
  entrez: '5138'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3A
  entrez: '5139'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1C
  entrez: '5137'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6A
  entrez: '5145'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE10A
  entrez: '10846'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8A
  entrez: '5151'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE9A
  entrez: '5152'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1B
  entrez: '5153'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8B
  entrez: '8622'
- word: (sGC)
  symbol: SGC
  source: hgnc_alias_symbol
  hgnc_symbol: SGCB
  entrez: '6443'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6C
  entrez: '5146'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7A
  entrez: '5150'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6B
  entrez: '5158'
chemicals:
- word: Ca2
  source: MESH
  identifier: D002118
- word: Na
  source: MESH
  identifier: D012964
- word: CGMP
  source: MESH
  identifier: C016276
- word: 5'GMP
  source: MESH
  identifier: D006157
diseases: []
---
